Specializing in synthetic DNA production, the company leverages its silicon-based DNA synthesis platform to serve industries such as healthcare, agriculture, and data storage. Investors monitor its growth due to its innovative approach and expanding applications in biotechnology and synthetic biology.
1 member of Congress has disclosed 2 trades in Twist Bioscience Corporation (TWST), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-03-30 | Dwight Evans | sell | $1K – $15K |
| 2020-03-02 | Dwight Evans | buy | $1K – $15K |